Immunotherapy of primary liver cancer. A control study of 51 patients. | IMSEAR

Main content 1 Search 2 Footer 3

+A A -A High contrast

Immunotherapy of primary liver cancer. A control study of 51 patients.

Plengvanit, U; Chearanai, O; Asavanich, C; Rungpitarangsi, B; Yongchaiyud, U; Viranuvatti, V.

Article in En | IMSEAR | ID: sea-39675

Subject(s)

Adenoma, Bile Duct/drug therapy; Adult; Bile Duct Neoplasms/drug therapy; Carcinoma, Hepatocellular/drug therapy; Female; Humans; Levamisole/therapeutic use; Liver Neoplasms/drug therapy; Male; Middle Aged

Search on Google

Full text: 1 Index: IMSEAR Main subject: Bile Duct Neoplasms / Female / Humans / Male / Levamisole / Adenoma, Bile Duct / Carcinoma, Hepatocellular / Adult / Liver Neoplasms / Middle Aged Language: En Year: 1986 Type: Article

Search on Google

Full text: 1 Index: IMSEAR Main subject: Bile Duct Neoplasms / Female / Humans / Male / Levamisole / Adenoma, Bile Duct / Carcinoma, Hepatocellular / Adult / Liver Neoplasms / Middle Aged Language: En Year: 1986 Type: Article